Valsartan HCTZ 160/25 APOTEX valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack

Active ingredient:

hydrochlorothiazide, Quantity: 25 mg; valsartan, Quantity: 160 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Hydrochlorothiazide,Valsartan

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: croscarmellose sodium; silicon dioxide; magnesium stearate; calcium hydrogen phosphate; hyprolose; powdered cellulose; hypromellose; titanium dioxide; iron oxide red; iron oxide black; iron oxide yellow

Administration route:

Oral

Units in package:

28

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Valsartan HCTZ is indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.

Product summary:

Visual Identification: Brown, modified, capsule shaped, film-coated tablets, engraved 'APO' on one side and '160/25' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-03-29